These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27402302)

  • 1. Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.
    Hensley PJ; Zetter D; Horbinski CM; Strup SE; Kyprianou N
    Hum Pathol; 2016 Nov; 57():68-77. PubMed ID: 27402302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.
    Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
    Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
    Ottley EC; Pell R; Brazier B; Hollidge J; Kartsonaki C; Browning L; O'Neill E; Kiltie AE
    J Pathol Clin Res; 2020 Oct; 6(4):238-251. PubMed ID: 32374509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.
    Zhao J; Dong D; Sun L; Zhang G; Sun L
    Int Braz J Urol; 2014; 40(2):179-89. PubMed ID: 24856504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubule-organizing center-mediated structural atypia in low- and high-grade urothelial carcinoma.
    Murata SI; Kuroda M; Kawamura N; Warigaya K; Musangile FY; Matsuzaki I; Kojima F
    Virchows Arch; 2021 Feb; 478(2):327-334. PubMed ID: 32710188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
    Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
    Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
    Breyer J; Gierth M; Shalekenov S; Aziz A; Schäfer J; Burger M; Denzinger S; Hofstädter F; Giedl C; Otto W
    World J Urol; 2016 May; 34(5):709-16. PubMed ID: 26394624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.
    Li C; Xue H; Lei Y; Zhu J; Yang B; Gai X
    Pathol Res Pract; 2014 Dec; 210(12):799-803. PubMed ID: 25445116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer.
    Shen CH; Wu JD; Jou YC; Cheng MC; Lin CT; Chen PC; Tseng YS; Shi CS; Chen SY; Chang DC; Lee YR
    J BUON; 2011; 16(4):733-7. PubMed ID: 22331730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.